Chris Mitton Appointed Chief Executive Officer; Jack Riccardi Appointed Chief Financial Officer.
MDNA Life Sciences will present at the Biotech Showcase 2016 to be held January 11-13, 2016, at the Parc 55 San Francisco.
Performance measurements from the first phase of our ongoing two-part validation study for the Prostate Core Mitomic Test™ for prostate cancer yield positive results.
Our tissue-based Mitomic Prostate Core Test™ receives positive results from an independent post-market study conducted by the prestigious uro-oncology trials management organization, CUSP Group.
The study will evaluate the Company’s novel mitochondrial DNA-based test for accurately identifying prostate cancer in blood samples from men with elevated PSA levels that are at risk for prostate cancer.